Company Overview of Igenica, Inc.
Igenica, Inc., a biopharmaceutical company, engages in the discovery and development of antibody-based therapeutics for the treatment of cancer. It develops recombinant monoclonal antibodies and treatments for multiple oncology indications. The company was founded in 2008 and is based in Burlingame, California.
863 Mitten Road
Burlingame, CA 94010
Founded in 2008
Key Executives for Igenica, Inc.
Igenica, Inc. Key Developments
Similar Private Companies By Industry
|Madison Vaccines, Inc.||United States|
|Altammune Inc.||United States|
|Stem Genetics Inc||United States|
|Integenx Acquisition Corp.||United States|
|AB Technology, Inc.||United States|
Recent Private Companies Transactions
January 8, 2015
To contact Igenica, Inc., please visit www.igenica.com. Company data is provided by Capital IQ. Please use this form to report any data issues.